Michael Campbell

Michael Campbell currently serves as the Associate Vice President of Global Risk Management and Safety Surveillance Science at Incyte, a role commenced in February 2022, where responsibilities include overseeing patient safety risk management activities and leading the GRMSS Scientist team. Prior experience at Incyte includes positions as Executive Director and Senior Director, demonstrating a consistent focus on safety surveillance and regulatory compliance. Earlier roles at Janssen Research and Development and Shire Pharmaceuticals further enhanced expertise in pharmacovigilance and risk management, including managing teams and ensuring adherence to global safety regulations. Educational qualifications include an MBA in International Business from Rosemont College, a Registered Nurse degree from Chester County Hospital School of Nursing, and a Bachelor of Science in Exercise Physiology from West Chester University of Pennsylvania.